Physician + engineer diligence.
Every claim cited.

Why Vantage

Different by design — and built to be trusted

The same diligence a senior physician and a biomedical engineer would run on your company — delivered faster, cheaper, and more completely than your realistic alternative, with every material factual claim traceable to a public source.

Every material claim cited. We never fabricate.

Every material factual claim in a Vantage report is cited to a real public source — an FDA filing, an SEC document, a ClinicalTrials.gov record, a USPTO patent, a CMS coverage decision. We never fabricate identifiers, trials, or comparables. As generic AI diligence floods the market, the output you can actually check — and stake a decision on — is the difference that compounds.

We don’t forecast winners. We make the knowable risks legible.

Vantage doesn’t claim to predict which companies succeed — early-stage outcomes turn on execution and luck no dataset can price. What we do is make the clinical, regulatory, and commercial risks that are knowable today legible, each one traced to a public source. Where a generic AI tool invents a 510(k) number or a trial to fill a gap, we cite every identifier to a real FDA, SEC, ClinicalTrials.gov, USPTO, or CMS record — or we tell you the data isn’t there.